ClinVar Miner

Submissions for variant NM_000535.7(PMS2):c.1591G>T (p.Glu531Ter)

gnomAD frequency: 0.00001  dbSNP: rs878854037
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 2
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Invitae RCV001388048 SCV001588869 pathogenic Hereditary nonpolyposis colorectal neoplasms 2016-02-13 criteria provided, single submitter clinical testing For these reasons, this variant has been classified as Pathogenic. While this particular variant has not been reported in the literature, truncating variants in PMS2 are known to be pathogenic (PMID: 21376568, 24362816). This sequence change creates a premature translational stop signal at codon 531 (p.Glu531*) of the PMS2 gene. It is expected to result in an absent or disrupted protein product.
Ambry Genetics RCV002399814 SCV002708984 pathogenic Hereditary cancer-predisposing syndrome 2018-05-02 criteria provided, single submitter clinical testing The p.E531* pathogenic mutation (also known as c.1591G>T), located in coding exon 11 of the PMS2 gene, results from a G to T substitution at nucleotide position 1591. This changes the amino acid from a glutamic acid to a stop codon within coding exon 11. This alteration is expected to result in loss of function by premature protein truncation or nonsense-mediated mRNA decay. As such, this alteration is interpreted as a disease-causing mutation.

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.